Represented QualTek USA, LLC in its acquisition of Broken Arrow Communications, Inc. ("BACOM"), a New Mexico-based private company that provides services for the installation, construction, and maintenance of wireless communication facilities. QualTek USA, LLC provides communication infrastructure construction services.
Represented Enochian Biosciences, a Los Angeles-based biopharmaceutical company focused in identifying, developing, manufacturing, and commercializing gene-modified cell therapy, in its Registered Direct Offering of US$29 million of common stock. H.C. Wainwright & Co., an investment bank in New York City, acted as Placement Agent. The client's stock surged at the morning bell and SPA was signed by 2:30 P.M., with no previous arrangement or agreement in existence between the parties.
Represented QualTek USA, LLC in its all-assets acquisitions of: a leading wireline installation and engineering services company in Canada, a cable and network installation company with operations across the United States, Recovery Logistics, LLC, a leading provider of business continuity and disaster recovery services, Site Resources, LLC, a company that does repairs and maintenance of wireless network infrastructures, Vertical Limit LLC, a provider of infrastructure services to the wireless telecommunications industry and Vinculums Services, LLC, the leading infrastructure service provider for wireless operators throughout the Western United States.
Represented a private equity client in the formation of a incentive plan for the management of one of its portfolio companies.
Represented the issuer in a private offering of convertible senior secured notes to a Florida-based private equity fund.
Represented investment banking firms in their investments in senior secured promissory notes from a public company issuers.
Represented a Chinese company with an Australian listing in preparation of all the disclosure documents for its U.S. initial public offering
Represented a small international shipping company based in the Channel Islands in its acquisition of a minority interest in a Florida based shipping company
Represented Anavex Life Sciences Corp. in its $50 million at-the-market offering program with Cantor Fitzgerald
Represented Lightwave Logic, Inc. in its acquisition of the polymer business of BrPhotonics Productos Optoelectrónicos S.A., a Brazilian company
Represented NeoGenomics, Inc. in its acquisition of all of the outstanding equity of Genoptix, Inc., a leading clinical oncology laboratory as well as its acquisition of the assets of the Oncology Division of Human Longevity, Inc.
Represented NeoGenomics, Inc. in its primary public offerings of common stock and convertible debt, as well as a secondary offering of equity by its largest shareholder.
Represented Grifols inconnection with its exchange offer of the existing U.S. publicly traded stock of the target for newly registered ADRs of Grifols. Represented the issuer through the initial public offering process for a foreign private issuer and in the years following regarding their reporting obligations.
Represented an Italian electric utility company in its offering and listing on the Irish Stock Exchange of €2.7 billion of hybrid capital securities
Represented one of the leading food suppliers in the UK in its initial debt issuance of £400 million of 9 7/8% senior notes and €340 million of 9 3/4% senior notes to finance its acquisition of a UK public company
Represented a Costa Rican food and beverage company in connection with its acquisition of a U.S. brewing company
Represented a Canadian public company with oil and gas operations principally in South America as issuer in connection with a number of Rule 144A/Reg. S offerings including: of $300 million of 7.25% senior unsecured notes, $1.0 billion in 5.125% senior unsecured notes, $1.3 billion in 5.375% senior unsecured notes along with a reopening of the 7.25% senior unsecured notes with an additional $300 million of notes
Represented a Colombian banking institution as issuer in connection with two Rule 144A/Reg. S offerings including: of $250 million of 7.5% senior subordinated notes and $300 million in 3.875% senior notes
Represented a Peruvian mining company with operations in Peru and Chile as a first time issuer in connection with a Rule 144A/Reg. S offering of $350 million of 4.625% senior notes
Represented Grifols, S.A. in the financing its acquisition of a U.S. public pharmaceutical company, through $1.1 billion of 8.25% senior notes. Later represented the issuer in its refinancing of its 8.25% notes with a new issuance of $1.0 billion of 5.25% senior notes.
Represented Dolphin Entertainment in its acquisitions of all of the equity of Be Social Public Relations, LLC and B/HI Communications, Inc.
Represented Brightstar Capital Partners in its acquisition of Brightstar Corp. from a Softbank affiliate.
Represented Dolphin Entertainment in its registered direct offering of common stock